These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Long-term survival of ischemic cardiomyopathy patients with severe left ventricular dysfunction after CABG vs heart transplantation: A single center retrospective analysis. Zhang T; Masroor M; Jiang C; Xu L; Wang Y; Deng C; Dong N Clin Transplant; 2024 Jan; 38(1):e15243. PubMed ID: 38289883 [TBL] [Abstract][Full Text] [Related]
24. Impact of mitral insufficiency on reoperative coronary artery surgery in ischemic cardiomyopathy patients. Wang N; Campwala S; Habibipour S; Hodgins D; Pai R; Razzouk A Eur J Cardiothorac Surg; 2004 Dec; 26(6):1118-28. PubMed ID: 15541972 [TBL] [Abstract][Full Text] [Related]
25. Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass. Pätilä T; Lehtinen M; Vento A; Schildt J; Sinisalo J; Laine M; Hämmäinen P; Nihtinen A; Alitalo R; Nikkinen P; Ahonen A; Holmström M; Lauerma K; Pöyhiä R; Kupari M; Kankuri E; Harjula A J Heart Lung Transplant; 2014 Jun; 33(6):567-74. PubMed ID: 24656645 [TBL] [Abstract][Full Text] [Related]
26. Early and late results of restrictive mitral valve annuloplasty in 121 patients with cardiomyopathy and chronic mitral regurgitation. Geidel S; Lass M; Krause K; Schneider C; Boczor S; Kuck KH; Ostermeyer J Thorac Cardiovasc Surg; 2008 Aug; 56(5):262-8. PubMed ID: 18615371 [TBL] [Abstract][Full Text] [Related]
27. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial. Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345 [TBL] [Abstract][Full Text] [Related]
28. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. Velazquez EJ; Lee KL; Jones RH; Al-Khalidi HR; Hill JA; Panza JA; Michler RE; Bonow RO; Doenst T; Petrie MC; Oh JK; She L; Moore VL; Desvigne-Nickens P; Sopko G; Rouleau JL; N Engl J Med; 2016 Apr; 374(16):1511-20. PubMed ID: 27040723 [TBL] [Abstract][Full Text] [Related]
29. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy. Akar AR; Durdu S; Arat M; Kilickap M; Kucuk NO; Arslan O; Kuzu I; Ozyurda U Eur J Cardiothorac Surg; 2009 Oct; 36(4):633-43. PubMed ID: 19524451 [TBL] [Abstract][Full Text] [Related]
30. Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. Chen S; Liu Z; Tian N; Zhang J; Yei F; Duan B; Zhu Z; Lin S; Kwan TW J Invasive Cardiol; 2006 Nov; 18(11):552-6. PubMed ID: 17090821 [TBL] [Abstract][Full Text] [Related]
31. Coronary artery bypass grafting with or without surgical ventricular restoration: a comparison. Prucz RB; Weiss ES; Patel ND; Nwakanma LU; Baumgartner WA; Conte JV Ann Thorac Surg; 2008 Sep; 86(3):806-14; discussion 806-14. PubMed ID: 18721565 [TBL] [Abstract][Full Text] [Related]
32. Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. Velazquez EJ; Williams JB; Yow E; Shaw LK; Lee KL; Phillips HR; O'Connor CM; Smith PK; Jones RH Ann Thorac Surg; 2012 Feb; 93(2):523-30. PubMed ID: 22269720 [TBL] [Abstract][Full Text] [Related]
33. Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation. Tolis GA; Korkolis DP; Kopf GS; Elefteriades JA Ann Thorac Surg; 2002 Nov; 74(5):1476-80; discussion 1480-1. PubMed ID: 12440595 [TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial. Pölzl L; Nägele F; Graber M; Hirsch J; Lobenwein D; Mitrovic M; Mayr A; Theurl M; Schreinlechner M; Pamminger M; Dorfmüller C; Grimm M; Gollmann-Tepeköylü C; Holfeld J Trials; 2020 May; 21(1):447. PubMed ID: 32473644 [TBL] [Abstract][Full Text] [Related]
35. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408 [TBL] [Abstract][Full Text] [Related]
36. Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). Stewart RA; Szalewska D; She L; Lee KL; Drazner MH; Lubiszewska B; Kosevic D; Ruengsakulrach P; Nicolau JC; Coutu B; Choudhary SK; Mark DB; Cleland JG; Piña IL; Velazquez EJ; Rynkiewicz A; White H JACC Heart Fail; 2014 Aug; 2(4):335-43. PubMed ID: 25023813 [TBL] [Abstract][Full Text] [Related]
37. Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]. Panza JA; Velazquez EJ; She L; Smith PK; Nicolau JC; Favaloro RR; Gradinac S; Chrzanowski L; Prabhakaran D; Howlett JG; Jasinski M; Hill JA; Szwed H; Larbalestier R; Desvigne-Nickens P; Jones RH; Lee KL; Rouleau JL J Am Coll Cardiol; 2014 Aug; 64(6):553-61. PubMed ID: 25104523 [TBL] [Abstract][Full Text] [Related]
38. Outcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium. Rizzello V; Poldermans D; Schinkel AF; Biagini E; Boersma E; Elhendy A; Sozzi FB; Palazzuoli A; Maat A; Crea F; Bax JJ Heart; 2007 Feb; 93(2):221-5. PubMed ID: 16905627 [TBL] [Abstract][Full Text] [Related]
39. Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial. Sant'Anna RT; Fracasso J; Valle FH; Castro I; Nardi NB; Sant'Anna JR; Nesralla IA; Kalil RA Rev Bras Cir Cardiovasc; 2014; 29(3):437-47. PubMed ID: 25372920 [TBL] [Abstract][Full Text] [Related]